CC
ROIV icon

Corton Capital’s Roivant Sciences ROIV Stock Holding History

Corton Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,112
Closed -$170K – 372
2025
Q2 		$170K Buy
15,112
+4,146
+38% +$44.9K 0.2% 264
2025
Q1 		$111K Buy
+10,966
New +$119K 0.37% 123
2024
Q3 		– Sell
-14,161
Closed -$150K – 640
2024
Q2 		$150K Sell
14,161
-73,710
-84% -$808K 0.08% 421
2024
Q1 		$926K Buy
87,871
+49,919
+132% +$538K 0.34% 38
2023
Q4 		$426K Buy
37,952
+10,716
+39% +$104K 0.14% 211
2023
Q3 		$318K Buy
27,236
+12,685
+87% +$143K 0.16% 184
2023
Q2 		$147K Buy
+14,551
New +$130K 0.07% 369

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Corton Capital's ROIV Position: Q3 2025 in Review

Corton Capital sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 15,112 shares — an estimated $170K sold.

Corton Capital first reported a position in ROIV in Q2 2023 and held it in 7 quarters. The position peaked at $926K in Q1 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Corton Capital reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Corton Capital sold 15,112 Roivant Sciences shares in Q3 2025, an estimated $170K.
  • Corton Capital first reported a position in Roivant Sciences in Q2 2023 and held it in 7 quarters.
  • Corton Capital's Roivant Sciences position peaked at $926K in Q1 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.